Health Care Equipment & Services

Insight on Stryker’s insider sale: Debra King’s August 18 sale shows routine liquidity moves while the company’s fundamentals remain strong, reassuring long‑term investors.

HIMS & HERS HEALTH insider sale: CEO’s 16,773‑share sale at $27.85 shows routine rebalancing, not a warning – investors can stay confident in the company’s steady growth.

Envista CFO buys 47,970 PSUs, showing strong management confidence and potential upside for investors amid rising stock price.

Cardinal Health insider sales by COO Mary Scherer show routine portfolio rebalancing, not a warning—stable fundamentals, strong growth, and strategic expansion remain in focus.

NEOGEN insider sales reflect routine vesting, while CEO and CFO buys confirm confidence; the company’s 110% YTD gain and diagnostics focus signal strong upside.

Advanced Biomed founder sells 176K shares at market price—no hidden signal, just a personal liquidity move. Stock remains steady, fundamentals strong.

Cardinal Health insider selling spree: CEO and execs liquidate ~150,000 shares, but strong earnings and routine vesting suggest no panic.

Rogers Campbell’s recent insider trades at HEARTFLOW show disciplined buying and selling, underscoring steady leadership confidence amid a 57% share‑price rally.

Insightful look at PACS Group’s insider sales: CEO’s liquidity strategy amid strong earnings, AI‑driven growth, and market confidence.

Explore Penumbra’s RSU‑driven strategy, high P/E upside, and tech‑driven growth in medical devices—key insights for investors seeking value and innovation.